226. 間質性膀胱炎(ハンナ型)
[臨床試験数:133,薬物数:151(DrugBank:46),標的遺伝子数:48,標的パスウェイ数:137

Searched query = "Interstitial cystitis with Hunners ulcer", "Interstitial cystitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-003367-23-DK
(EUCTR)
06/02/200621/12/2005A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of YM672 in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis - Not availableA Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of YM672 in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis - Not available Interstitial Cystitis / Painful Bladder Syndrome
MedDRA version: 8.0;Level: LLT;Classification code 10008928
Trade Name: IPD® (suplatast tosilate)
Product Name: YM672 (IPD®)
Product Code: YM672
INN or Proposed INN: Suplatast tosilate
Other descriptive name: IPD® (Japanese tradename)
Astellas Pharma Europe B.V.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
150Phase 2Denmark;Germany;Sweden
2EUCTR2005-003367-23-SE
(EUCTR)
01/02/200606/12/2005A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of YM672 in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis - Not availableA Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of YM672 in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis - Not available Interstitial Cystitis / Painful Bladder Syndrome
MedDRA version: 8.0;Level: LLT;Classification code 10008928
Trade Name: IPD® (suplatast tosilate)
Product Name: YM672 (IPD®)
Product Code: YM672
INN or Proposed INN: Suplatast tosilate
Other descriptive name: IPD® (Japanese tradename)
Astellas Pharma Europe B.V.NULLNot RecruitingFemale: yes
Male: yes
150Phase 2Germany;Sweden